Wednesday, May 29, 2013

Reuters: Health News: GSK bets on chimp virus with $321 million vaccines buy

GSK bets on chimp virus with $321 million vaccines buy

LONDON (Reuters) - GlaxoSmithKline is betting on a new vaccine technology based on chimpanzee viruses by acquiring Swiss-based Okairos for 250 million...

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/NfgxvGZ5bMI/story01.htm


No comments:

Post a Comment

Subscribe Now: Feed Icon